Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

The tune has become nostalgic for many, as highlighted by numerous viral videos on social media, as it once symbolised the end of the weekend. For 90s kids, it was the unmistakable nudge that ...